Synthesis, Biological Activity and DFT Studies of 1,3,4-oxadiazole Ring in Combination with Pyridinium Salt

Author:

Rababa Mohammad H.1,Alsaleh Majd M.2,Abusamhadaneh Alaa A.3,Younes Eyad A.4,Natsheh Iyad Y.2,Rasras Anas J.1ORCID

Affiliation:

1. Department of Chemistry, Faculty of Science, Al-Balqa Applied University, Al-Salt, PO Box 19117, Jordan

2. Department of Allied Medical Sciences, Al-Balqa Applied University, Al-Salt, Jordan

3. Department of Medical Laboratory Science, Faculty of Science, Al-Balqa Applied University, Jordan

4. Department of Chemistry, Faculty of Science, The Hashemite University, PO Box 330127, Zarqa 13133, Jordan

Abstract

Aims: In this study, the synthesis and biological activity of new 1,3,4-oxadiazole derivatives will be discussed. Background: Microbial contagion via different bacterial strains discomposes the healthcare system globally. In 2019 E. coli, S. aureus, K. pneumoniae, and S. pneumoniae were reported as the most bacteremia deaths causes. Over time, bacteria develop different ways to overcome antibiotic activity, causing multidrug resistant bacteria (MDR). The MDR is considered one of the biggest concerns to scientists worldwide due to its direct effect on patients' lives. As a result, developing new drugs has become imperative for scientists to protect human life. Objective: Developing new water soluble antibacterial drugs from cheap and commercially available materials. Methods: Microdilution Assay Antimicrobial potential was performed based on the reported experimental procedure with slight modifications. Briefly, chemical preparations were serially diluted (2-fold) ten times with Muller Hinton broth. Well number eleven was considered a negative control of bacterial growth, while well number twelve contained nutrient broth only and was used as a positive control for bacterial growth. The achieved ten concentrations of the chemical solutions were from 10 mg/mL to 9 μg/mL. A serial two-fold dilution of DMSO with Muller Hinton broth was prepared to ensure that the antimicrobial potential was not from DMSO. Moreover, the blank or the background was a two-fold dilution for each chemical with broth. The final bacterial concentration in each well (except positive control) was adjusted to 0.75 × 106 CFU/ml. After the inoculation of bacteria, the plates were covered and incubated overnight at 37oC for 24 hours. The plates were then scanned with an enzyme-linked immunosorbent assay (ELISA) reader at 600 Nano moles to examine the bacterial density. The lowest concentration of the chemical that did not allow any visible microbial growth in the test broth was considered the minimal inhibitory concentration (MIC), which was then further confirmed by culturing each (MIC) well on Muller Henton agar and incubating overnight at 37oC for twenty-four hours. The molecular geometries of compounds 4a, 4e, 4j, and 4p were optimized at the B3LYP/6-311+G(d,p) level of theory using DFT calculations. Results: The antimicrobial examination results show that compound 4j has an interesting activity against E. faecium with MIC value of 9 μg/mL. However, it was found to have low activity against E.coli and K. pneumoniae with an MIC value of 625 μg/mL. On the other hand, compound 4e showed very good activity against E.coli with an MIC value of 78 μg/mL and good activity against K. pneumoniae with an MIC value of 312 μg/mL. The structural properties were further investigated by density functional theory (DFT) calculations. The most biologically active compounds 4e and 4j were optimized in the gas phase using B3LYP method and 6-31+G(d,p) as a bases set. The resulting ground-state structures take a V shape as the two conjugated system are connected by methylene group. The molecular electrostatic potential map (MEP) of 4e and 4j was calculated and the results indicate that, the most intense blue region with the largest positive potential is distributed over the pyridinium ring, which indicates its binding with the chloride ion.

Publisher

Bentham Science Publishers Ltd.

Subject

Organic Chemistry

Reference25 articles.

1. Antibiotic resistance World Health Oragnaizatio (WHO)Available from: 2020

2. Murray C.J.L.; Ikuta K.S.; Sharara F.; Swetschinski L.; Robles Aguilar G.; Gray A.; Han C.; Bisignano C.; Rao P.; Wool E.; Johnson S.C.; Browne A.J.; Chipeta M.G.; Fell F.; Hackett S.; Haines-Woodhouse G.; Kashef Hamadani B.H.; Kumaran E.A.P.; McManigal B.; Agarwal R.; Akech S.; Albertson S.; Amuasi J.; Andrews J.; Aravkin A.; Ashley E.; Bailey F.; Baker S.; Basnyat B.; Bekker A.; Bender R.; Bethou A.; Bielicki J.; Boonkasidecha S.; Bukosia J.; Carvalheiro C.; Castañeda-Orjuela C.; Chansamouth V.; Chaurasia S.; Chiurchiù S.; Chowdhury F.; Cook A.J.; Cooper B.; Cressey T.R.; Criollo-Mora E.; Cunningham M.; Darboe S.; Day N.P.J.; De Luca M.; Dokova K.; Dramowski A.; Dunachie S.J.; Eckmanns T.; Eibach D.; Emami A.; Feasey N.; Fisher-Pearson N.; Forrest K.; Garrett D.; Gastmeier P.; Giref A.Z.; Greer R.C.; Gupta V.; Haller S.; Haselbeck A.; Hay S.I.; Holm M.; Hopkins S.; Iregbu K.C.; Jacobs J.; Jarovsky D.; Javanmardi F.; Khorana M.; Kis-soon N.; Kobeissi E.; Kostyanev T.; Krapp F.; Krumkamp R.; Kumar A.; Kyu H.H.; Lim C.; Limmathurotsakul D.; Loftus M.J.; Lunn M.; Ma J.; Mturi N.; Mu-nera-Huertas T.; Musicha P.; Mussi-Pinhata M.M.; Nakamura T.; Nanavati R.; Nangia S.; Newton P.; Ngoun C.; Novotney A.; Nwakanma D.; Obiero C.W.; Olivas-Martinez A.; Olliaro P.; Ooko E.; Ortiz-Brizuela E.; Peleg A.Y.; Perrone C.; Plakkal N.; Ponce-de-Leon A.; Raad M.; Ramdin T.; Riddell A.; Roberts T.; Robotham J.V.; Roca A.; Rudd K.E.; Russell N.; Schnall J.; Scott J.A.G.; Shivamallappa M.; Sifuentes-Osornio J.; Steenkeste N.; Stewardson A.J.; Stoeva T.; Tasak N.; Thai-prakong A.; Thwaites G.; Turner C.; Turner P.; van Doorn H.R.; Velaphi S.; Vongpradith A.; Vu H.; Walsh T.; Waner S.; Wangrangsimakul T.; Wozniak T.; Zheng P.; Sartorius B.; Lopez A.D.; Stergachis A.; Moore C.; Dolecek C.; Naghavi M.; Global burden of bacterial antimicrobial resistance in 2019: A systematic analysis. Lancet 2022,399(10325),629-655

3. Chebotar’ I.V.; Emelyanova M.A.; Bocharova J.A.; Mayansky N.A.; Kopantseva E.E.; Mikhailovich V.M.; The classification of bacterial survival strategies in the presence of antimicrobials. Microb Pathog 2021,155,104901

4. Liu Y.; Tong Z.; Shi J.; Li R.; Upton M.; Wang Z.; Drug repurposing for next-generation combination therapies against multidrug-resistant bacteria. Theranostics 2021,11(10),4910-4928

5. Tansarli G.S.; Karageorgopoulos D.E.; Kapaskelis A.; Falagas M.E.; Impact of antimicrobial multidrug resistance on inpatient care cost: An evaluation of the evidence. Expert Rev Anti Infect Ther 2013,11(3),321-331

Cited by 2 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3